Straumann Holding AG (OTCMKTS:SAUHY) Sees Large Increase in Short Interest

Straumann Holding AG (OTCMKTS:SAUHY) was the recipient of a significant growth in short interest in September. As of September 30th, there was short interest totaling 44,911 shares, a growth of 669.4% from the September 15th total of 5,837 shares. Based on an average daily volume of 130,960 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.0% of the company’s stock are sold short.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on SAUHY shares. UBS Group raised Straumann from a “neutral” rating to a “buy” rating in a research report on Tuesday, September 1st. Berenberg Bank raised Straumann to a “strong-buy” rating in a research note on Thursday, September 17th. The Goldman Sachs Group raised Straumann from a “neutral” rating to a “buy” rating in a research note on Monday, September 14th. Deutsche Bank Aktiengesellschaft downgraded Straumann from a “buy” rating to a “hold” rating in a report on Friday, August 21st. Finally, Morgan Stanley reiterated an “underweight” rating on shares of Straumann in a research note on Tuesday, June 30th. One research analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, Straumann has a consensus rating of “Moderate Buy”.

Straumann Trading Up 2.5%

OTCMKTS:SAUHY traded up $0.26 during trading hours on Friday, reaching $10.76. The company’s stock had a trading volume of 136,860 shares, compared to its average volume of 78,702. Straumann has a one year low of $9.44 and a one year high of $13.61. The business’s 50-day moving average is $11.72 and its 200-day moving average is $11.66.

Straumann Company Profile

Straumann Group is a Swiss company focused on implant, restorative and orthodontic dentistry. The company develops, manufactures and distributes dental implants, prosthetic components, instruments and related solutions used by dental professionals and laboratories.

Its portfolio also includes biomaterials for tissue regeneration, digital dentistry technologies and intraoral scanning solutions, as well as clear aligners offered through its ClearCorrect business. Straumann provides products and services intended to support dental restoration, tooth replacement, orthodontic treatment and digital treatment planning.

Founded in 1954 and headquartered in Basel, Switzerland, Straumann serves dental professionals, laboratories and patients through operations and distribution networks across numerous markets worldwide.